Research & Benchmarking Executive Summary: the Emerging Role of Artificial Intelligence (Ai) in Supply Chain Management

Online pre-registration for DCAT Week 2024 is now closed. To register for programs and events onsite, visit the DCAT Office located in the Barclay Salon on the first floor of the InterContinental Barclay. Office hours can be found here. 

Artificial intelligence (AI) has created enormous interest across all industries for its potential to create new products, increase productivity, and enhance sustainability efforts, including procurement and supply-chain management. Despite its potential, however, separating reality from the promise of AI has been a challenge, and its adoption has been slowed by perceptions relating to its cost and the complexity of applying it.

Although the bio/pharma industry is readily adopting AI in drug discovery and marketing, companies are just starting to pilot use cases for AI in supply-chain management. Still, bio/pharma companies and their suppliers need to understand what is AI’s potential in supply-chain management and how may it shape how companies do business in the supply of direct materials used in bio/pharma development and manufacturing.

To gain a perspective on the role and potential of AI in supply-chain management in the bio/pharma industry, the Drug, Chemical & Associated Technologies Association (DCAT), through the DCAT Research & Benchmarking Committee, conducted a study on how companies are using AI or view its potential in supply-chain management. The survey was fielded to senior and mid-level executives in DCAT Member Companies—bio/pharma companies and suppliers—to gain their feedback.

Hear the key take-ways from that study, The Emerging Role of Artificial Intelligence (AI) in Supply Chain Management. Gain expert views on the role of AI in sourcing and supply management—its potential, the types of projects and activities for which AI may be applied, and its challenges to use and adoption. This program will help bio/pharma companies and their suppliers understand how the adoption of AI will impact how they work together and how it might change their relationship.

Panel Discussion

Hear from an expert panel on how AI is changing supply-chain management and procurement and is helping companies be more proactive in managing their supply chains.

• Koray Köse, Chief Industry Officer, Everstream Analytics
• Martin Rand, CEO, Pactum
• David McCarthy, Senior Director, Enablement & Strategic Insights, Pfizer
• Jeet Sarkar, Global Head of IT at SK pharmteco

Panel moderator: Vishal Bhandari, Partner, Healthcare & Life Sciences Practice and Co-Leader, Global Life Sciences’ Sector, Kearney

Gain answers to these all-important questions:

Will your next supply deal be negotiated by AI?

• Companies with large numbers of global suppliers are using AI applications to manage supplier relationships and negotiate supply deals
• Pactum AI is a leader in AI-driven supplier-management applications, counting Walmart and Medline among its clients

Can AI protect your company from costly supply-chain disruptions?

• AI-based applications can anticipate the risks of geopolitical, climate and economic events so that companies can proactively prepare for, even prevent, interruptions to even the lowest tier of their supply chains.
• Everstream Analytics is a leading provider of services to monitor and anticipate potential supply-chain disruptions, and is used by a number of bio/pharmaceutical companies.

About DCAT Research & Benchmarking

DCAT Research & Benchmarking is a complimentary, value-added member benefit providing in-depth studies that examine the crucial issues impacting the bio/pharmaceutical manufacturing value chain and the bio/pharma customer—supplier relationship. DCAT Research & Benchmarking studies are developed by the DCAT Research & Benchmarking Committee, composed of representatives of DCAT Member Companies with diverse industry experience, to identify the topics of greatest interest for DCAT Member Companies. The studies are administered and prepared using an external research firm.

Who Should Attend?

• C-suite and senior to mid-level executives of bio/pharmaceutical companies, including those involved in sourcing, procurement, supply management, and manufacturing.
• C-suite and senior to mid-level executives of CDMOs/CMOs and other suppliers, including those in business development, sales, marketing, and operational functions in support of bio/pharmaceutical development and manufacturing.

Price & Registration

Online pre-registration for DCAT Week 2024 is now closed. To register for programs and events onsite, visit the DCAT Office located in the Barclay Salon on the first floor of the InterContinental Barclay. Office hours can be found here. 

DCAT Member Company Price: Complimentary

Please note: DCAT Week 2024 programs are available to employees of DCAT Member Companies only. Not sure if your company is a DCAT member? Click here or call DCAT at 1-609-208-1888.

Attending DCAT Week Programs

All materials provided to registrants (including slides, reports, and presented information) are only for their reference. Registrants may not copy, photograph, or redistribute any materials, and they are responsible for any claim for violations of copyright or other intellectual property rights.